ロード中...
SUN-448 Giant Prolactinomas: A Follow-Up of 25 Years with Dopamine Agonists
Giant prolactinomas are tumors with a large size > 4 cm and/or prolactin levels higher than 3000 ng/ml and/or highly invasive growth. Today dopamine agonists, mainly cabergoline (CAB), are the first-line choice in the treatment of these tumors. Objective: To assess the efficacy, safety and long-t...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Endocrine Society
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553132/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-448 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|